Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other Non-Current Liabilities: 2023-2025

  • CG Oncology's Other Non-Current Liabilities was N/A to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year change of. This contributed to the annual value of $365,000 for FY2023, which is N/A change from last year.
  • CG Oncology's Other Non-Current Liabilities amounted to $3.8 million in Q3 2025, which was up 942.19% from $365,000 recorded in Q4 2023.
  • CG Oncology's 5-year Other Non-Current Liabilities high stood at $3.8 million for Q3 2025, and its period low was $365,000 during Q4 2023.
  • In the last 2 years, CG Oncology's Other Non-Current Liabilities had a median value of $2.1 million in 2023 and averaged $2.1 million.